Latest articles from Cancer Therapy Advisor Skin Cancer
The approval was supported by data from the phase 3, multicenter, randomized, double-blind, placebo-controlled EORTC1325/KEYNOTE-054 trial (N=1019) which included patients with completely resected stage IIIA (>1mm lymph node m…
Concerns about conflict of interest as it relates to prescribing may never go away, some say, as long as drug companies offer doctors money for consulting and personal services. from Latest articles from Cancer Therapy Advisor …
In a statement announcing a newly created partnership, the Botanical Safety Consortium, FDA Commissioner Scott Gottlieb made no mention of cannabidiol. from Latest articles from Cancer Therapy Advisor Skin Cancer http://bit.ly/…
"People have shown that the variant-identification quality of WGS is superior to WES," said Dr Gerstein. from Latest articles from Cancer Therapy Advisor Skin Cancer http://bit.ly/2Ib0XoE
Articles discussing the use of cannabis as a substitute for opioids highlight the limitations of the existing scientific evidence in the field. from Latest articles from Cancer Therapy Advisor Skin Cancer http://bit.ly/2SjbAKA�…
The continuous decline in cancer deaths over the past 25 years was attributed to improvements in screening, treatment. from Latest articles from Cancer Therapy Advisor Skin Cancer http://bit.ly/2HXijVI
Experts examined the role of population-based early detection cancer screening. from Latest articles from Cancer Therapy Advisor Skin Cancer http://bit.ly/2HPQ3ED
Researchers are excited about the prospect to use vaccines in combination with checkpoint inhibitors to improve the body's cancer-fighting ability. from Latest articles from Cancer Therapy Advisor Skin Cancer http://bit.ly/…
Inhibition of ER translocation prevented both ERK reactivation and autophagy, suggesting a potential strategy for improving BRAF and MEK inhibition therapy outcomes. from Latest articles from Cancer Therapy Advisor Skin Cancer …
QoL for patients with cancer is reduced just as much by the accumulation of low-level toxicities as it is from high-level adverse events. from Latest articles from Cancer Therapy Advisor Skin Cancer http://bit.ly/2GcArIK
Patients in close contact with the health care system are more likely to get diagnosed with skin cancer, suggesting the possibility of detection bias in studies. from Latest articles from Cancer Therapy Advisor Skin Cancer http…
Eight in 10 patients with DFSP saw a clinical benefit from treatment with imatinib. from Latest articles from Cancer Therapy Advisor Skin Cancer http://bit.ly/2snD963
Tissue-resident memory CD8+ T cells helped suppress melanoma in an animal study. from Latest articles from Cancer Therapy Advisor Skin Cancer http://bit.ly/2RBFWqL
Use of real-world data has the potential to accelerate drug and device approvals in rare diseases and advance precision medicine initiatives. from Latest articles from Cancer Therapy Advisor Skin Cancer http://bit.ly/2SNFQcG
The use of AI in the diagnosis of skin cancer has real potential, yet current algorithms lack standardization and regulatory approval. from Latest articles from Cancer Therapy Advisor Skin Cancer http://bit.ly/2s9JJNy
Current treatment guidelines do not adequately cover what kind of surveillance and treatment should apply to patients with melanoma after a negative sentinel node biopsy. from Latest articles from Cancer Therapy Advisor Skin Ca…
The Food and Drug Administration has granted accelerated approval to Keytruda (pembrolizumab; Merck) for the treatment of patients with recurrent locally advanced or metastatic Merkel cell carcinoma. from Latest articles from C…
In mice, DNA-encoded plasmids generated sufficient in vivo expression of immune checkpoint antibody CTLA-4; DMabs may one day rival traditional mAbs. from Latest articles from Cancer Therapy Advisor Skin Cancer https://ift.tt/2…
Researchers are learning that roughly half of survivors live with a moderate to high degreeof fear of recurrence, and teaching techniques to better cope with uncertainty is one way tohelp. from Latest articles from Cancer Thera…
Dacarbazine, although once a staple of melanoma therapy, essentially has no current role in the treatment of any type or stage of melanoma. from Latest articles from Cancer Therapy Advisor Skin Cancer https://ift.tt/2QlxGLq
